Pembrolizumab-Associated CD8+ Vasculitic Mononeuritis Multiplex in a Patient With Mesothelioma
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received November 25, 2020
- Accepted in final form February 22, 2021
- First Published April 6, 2021.
Author Disclosures
- Michaela C. Baldauf, MD (michaela.baldauf@kssg.ch),
- Monika Kapauer, MD (monika.kapauer@kssg.ch),
- Markus Joerger, MD (markus.joerger@kssg.ch),
- Lukas Flatz, MD (lukas.flatz@kssg.ch),
- Regulo Rodriguez, MD (regulo.rodriguez@kssg.ch),
- Stephan Frank, MD (stephan.frank@usb.ch),
- Ansgar Felbecker, MD (ansgar.felbecker@kssg.ch),
- Susanne Hartmann-Fussenegger, MD (susanne.hartmann-fussenegger@kssg.ch) and
- Thomas Hundsberger, MD
- Michaela C. Baldauf, MD (michaela.baldauf@kssg.ch),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Monika Kapauer, MD (monika.kapauer@kssg.ch),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Markus Joerger, MD (markus.joerger@kssg.ch),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Lukas Flatz, MD (lukas.flatz@kssg.ch),
(1) Novartis (2) Bristol-Myers Squibb
NONE
NONE
NONE
Arenavirus vaccine based vectors as cancer vaccines
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Swiss National Science Foundation (2) Swiss Cancer League
NONE
(1) Arenavirus based vaccine vectors, source of payment (Hookipa Pharma)
NONE
NONE
NONE
NONE
- Regulo Rodriguez, MD (regulo.rodriguez@kssg.ch),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stephan Frank, MD (stephan.frank@usb.ch),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ansgar Felbecker, MD (ansgar.felbecker@kssg.ch),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Susanne Hartmann-Fussenegger, MD (susanne.hartmann-fussenegger@kssg.ch) and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Thomas Hundsberger, MD
(1)Bayer, Switzerland (2)Sanofi/Genzyme, Switzerland (3) Novocure, Switzerland
NONE
NONE
NONE
NONE
NONE
NONE
(1) Sanofi/Genzyme, Switzerland
NONE
NONE
NONE
(1) Baxter, Switzerland
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (M.C.B., M.K., A.F., S.H.-F.); Department of Hematology and Oncology (M.J.); Department of Dermatology (L.F.); Department of Pathology (R.R.), Cantonal Hospital, St. Gallen; Department of Pathology (S.F.), University Hospital, Basel; and Department of Neurology and Department of Hematology and Oncology (T.H.), Cantonal Hospital St. Gallen, Switzerland.
- Correspondence
Dr. Hundsberger thomas.hundsberger{at}kssg.ch
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Research
Nerve sonography to detect peripheral nerve involvement in vasculitis syndromesH. Stephan Goedee, W. Ludo van der Pol, Jan-Thies H. van Asseldonk et al.Neurology: Clinical Practice, May 19, 2016 -
Article
Neurologic autoimmunity and immune checkpoint inhibitorsAutoantibody profiles and outcomesElia Sechi, Svetomir N. Markovic, Andrew McKeon et al.Neurology, August 13, 2020 -
Article
Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathiesDivyanshu Dubey, William S. David, Anthony A. Amato et al.Neurology, August 12, 2019 -
Article
Painful vasculitic neuropathy in HIV-1 infectionRelief of pain with prednisone therapyWalter G. Bradley, Ashok Verma et al.Neurology, December 01, 1996